Hundreds of drugs are approved in the U.S. every year, but GoodRx recently listed one dozen approvals that it said were the most influential for 2023.
The report by GoodRx, a digital pharmaceutical platform, highlighted drugs that it said represented a major advancement compared to other treatment options.
The new list came as the U.S. public has been hearing a lot about weight-loss drugs such as Ozempic and Wegovy; and a new drug in that category, Zepbound, is included on the GoodRx list. However, the list includes a wide range of drugs and vaccines, including a contraceptive, treatments for respiratory diseases, and a treatment for Alzheimer's disease.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
